SAM
Strategy Asset Managers’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.42M | Buy |
6,232
+374
| +6% | +$145K | 0.45% | 54 |
|
2025
Q1 | $2.55M | Buy |
5,858
+118
| +2% | +$51.3K | 0.53% | 53 |
|
2024
Q4 | $2.12M | Sell |
5,740
-1,203
| -17% | -$444K | 0.41% | 57 |
|
2024
Q3 | $3.61M | Sell |
6,943
-2,020
| -23% | -$1.05M | 0.69% | 44 |
|
2024
Q2 | $3.98M | Buy |
8,963
+2,446
| +38% | +$1.09M | 0.88% | 36 |
|
2024
Q1 | $3.38M | Buy |
6,517
+163
| +3% | +$84.5K | 0.72% | 42 |
|
2023
Q4 | $3M | Buy |
6,354
+331
| +5% | +$156K | 0.71% | 39 |
|
2023
Q3 | $2.62M | Sell |
6,023
-2,940
| -33% | -$1.28M | 0.69% | 41 |
|
2023
Q2 | $3.98M | Buy |
8,963
+1,243
| +16% | +$552K | 0.88% | 36 |
|
2023
Q1 | $3.55M | Buy |
7,720
+2,361
| +44% | +$1.09M | 0.87% | 37 |
|
2022
Q4 | $2.75M | Sell |
5,359
-36
| -0.7% | -$18.5K | 0.7% | 38 |
|
2022
Q3 | $2.45M | Buy |
5,395
+105
| +2% | +$47.7K | 0.67% | 44 |
|
2022
Q2 | $2.55M | Buy |
5,290
+176
| +3% | +$84.9K | 0.79% | 39 |
|
2022
Q1 | $2.51M | Buy |
5,114
+1,505
| +42% | +$739K | 0.54% | 51 |
|
2021
Q4 | $1.67M | Sell |
3,609
-254
| -7% | -$118K | 0.43% | 50 |
|
2021
Q3 | $1.44M | Buy |
3,863
+275
| +8% | +$103K | 0.32% | 66 |
|
2021
Q2 | $1.37M | Buy |
+3,588
| New | +$1.37M | 0.29% | 69 |
|
2018
Q3 | – | Sell |
-11,197
| Closed | -$2.67M | – | 146 |
|
2018
Q2 | $2.67M | Sell |
11,197
-430
| -4% | -$102K | 0.56% | 57 |
|
2018
Q1 | $2.55M | Buy |
+11,627
| New | +$2.55M | 0.55% | 61 |
|
2016
Q1 | – | Sell |
-20,378
| Closed | -$2.84M | – | 148 |
|
2015
Q4 | $2.84M | Buy |
20,378
+104
| +0.5% | +$14.5K | 0.65% | 48 |
|
2015
Q3 | $2.84M | Sell |
20,274
-56
| -0.3% | -$7.84K | 0.68% | 41 |
|
2015
Q2 | $3.34M | Sell |
20,330
-164
| -0.8% | -$26.9K | 0.74% | 38 |
|
2015
Q1 | $3.16M | Buy |
+20,494
| New | +$3.16M | 0.69% | 44 |
|